Peter Zhang is an experienced scientist with a strong background in biotechnology and immunotherapy. Currently serving as a Scientist at AvenCell since May 2023, previous roles include Scientist at SOTIO Biotech and Senior Associate Scientist at ElevateBio. Peter's expertise encompasses T cell adoptive immunotherapy, CAR and TCR characterization, and various immunological assays. Notable skills include multi-parameter flow cytometry, T cell engineering using CRISPR technology, and functional assays for T cell analysis. Peter also has experience in antibody discovery during a research co-op at EMD Serono, Inc. and has contributed to optimizing detection technology at Confer Health, Inc. Peter holds a Master's degree in Biotechnology from Northeastern University and a Bachelor's degree in Cell/Cellular and Molecular Biology from San Francisco State University.
This person is not in any teams
This person is not in any offices